663 related articles for article (PubMed ID: 23543530)
41. [Treatment of uraemic anorexia with megestrol acetate].
Fernández Lucas M; Teruel JL; Burguera V; Sosa H; Rivera M; Rodríguez Palomares JR; Marcén R; Quereda C
Nefrologia; 2010; 30(6):646-52. PubMed ID: 21113214
[TBL] [Abstract][Full Text] [Related]
42. A randomised, double blind, placebo-controlled trial of megestrol acetate or dexamethasone in treating symptomatic anorexia in people with advanced cancer.
Currow DC; Glare P; Louw S; Martin P; Clark K; Fazekas B; Agar MR
Sci Rep; 2021 Jan; 11(1):2421. PubMed ID: 33510313
[TBL] [Abstract][Full Text] [Related]
43. High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials.
Maltoni M; Nanni O; Scarpi E; Rossi D; Serra P; Amadori D
Ann Oncol; 2001 Mar; 12(3):289-300. PubMed ID: 11332139
[TBL] [Abstract][Full Text] [Related]
44. The effect of cyproheptadine hydrochloride (periactin) and megestrol acetate (megace) on weight in children with cancer/treatment-related cachexia.
Couluris M; Mayer JL; Freyer DR; Sandler E; Xu P; Krischer JP
J Pediatr Hematol Oncol; 2008 Nov; 30(11):791-7. PubMed ID: 18989154
[TBL] [Abstract][Full Text] [Related]
45. Pharmacological treatment of geriatric cachexia: evidence and safety in perspective.
Yeh SS; Lovitt S; Schuster MW
J Am Med Dir Assoc; 2007 Jul; 8(6):363-77. PubMed ID: 17619035
[TBL] [Abstract][Full Text] [Related]
46. Palliative treatment of cancer anorexia with oral suspension of megestrol acetate.
Tomíska M; Tomisková M; Salajka F; Adam Z; Vorlícek J
Neoplasma; 2003; 50(3):227-33. PubMed ID: 12937858
[TBL] [Abstract][Full Text] [Related]
47. Treatment of anorexia and weight loss with megestrol acetate in patients with cystic fibrosis.
Nasr SZ; Hurwitz ME; Brown RW; Elghoroury M; Rosen D
Pediatr Pulmonol; 1999 Nov; 28(5):380-2. PubMed ID: 10536070
[TBL] [Abstract][Full Text] [Related]
48. A retrospective study of the association between megestrol acetate administration and mortality among nursing home residents with clinically significant weight loss.
Bodenner D; Spencer T; Riggs AT; Redman C; Strunk B; Hughes T
Am J Geriatr Pharmacother; 2007 Jun; 5(2):137-46. PubMed ID: 17719516
[TBL] [Abstract][Full Text] [Related]
49. Cytokine activity in cancer-related anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate.
Mantovani G; Macciò A; Lai P; Massa E; Ghiani M; Santona MC
Semin Oncol; 1998 Apr; 25(2 Suppl 6):45-52. PubMed ID: 9625383
[TBL] [Abstract][Full Text] [Related]
50. Megestrol acetate in cachexia and anorexia.
Yeh SS; Schuster MW
Int J Nanomedicine; 2006; 1(4):411-6. PubMed ID: 17722275
[TBL] [Abstract][Full Text] [Related]
51. Megestrol acetate therapy for anorexia and weight loss in children with malignant solid tumours.
Azcona C; Castro L; Crespo E; Jiménez M; Sierrasesúmaga L
Aliment Pharmacol Ther; 1996 Aug; 10(4):577-86. PubMed ID: 8853762
[TBL] [Abstract][Full Text] [Related]
52. Anorexia/cachexia in patients with HIV: lessons for the oncologist.
Von Roenn JH; Knopf K
Oncology (Williston Park); 1996 Jul; 10(7):1049-56; discussion 1062-4, 1067-8. PubMed ID: 8837121
[TBL] [Abstract][Full Text] [Related]
53. Usefulness of megestrol acetate in cancer cachexia and anorexia. A placebo-controlled study.
Feliu J; González-Barón M; Berrocal A; Artal A; Ordóñez A; Garrido P; Zamora P; García de Paredes ML; Montero JM
Am J Clin Oncol; 1992 Oct; 15(5):436-40. PubMed ID: 1524045
[TBL] [Abstract][Full Text] [Related]
54. Appetite stimulants in cystic fibrosis: a systematic review.
Chinuck RS; Fortnum H; Baldwin DR
J Hum Nutr Diet; 2007 Dec; 20(6):526-37. PubMed ID: 18001374
[TBL] [Abstract][Full Text] [Related]
55. Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group.
Beller E; Tattersall M; Lumley T; Levi J; Dalley D; Olver I; Page J; Abdi E; Wynne C; Friedlander M; Boadle D; Wheeler H; Margrie S; Simes RJ
Ann Oncol; 1997 Mar; 8(3):277-83. PubMed ID: 9137798
[TBL] [Abstract][Full Text] [Related]
56. [Low doses of megestrol acetate increase weight and improve nutrition status in patients with severe chronic obstructive pulmonary disease and weight loss].
Herrejón A; Palop J; Inchaurraga I; López A; Bañuls C; Hernández A; Blanquer R; Están N; Anguera A
Med Clin (Barc); 2011 Jul; 137(5):193-8. PubMed ID: 21524765
[TBL] [Abstract][Full Text] [Related]
57. Appetite stimulants: the unsolved truth.
Baron M
Health Care Food Nutr Focus; 2000 Jun; 16(10):5-7. PubMed ID: 11182996
[No Abstract] [Full Text] [Related]
58. A Systematic Review and Meta-Analysis of the Clinical Use of Megestrol Acetate for Cancer-Related Anorexia/Cachexia.
Lim YL; Teoh SE; Yaow CYL; Lin DJ; Masuda Y; Han MX; Yeo WS; Ng QX
J Clin Med; 2022 Jun; 11(13):. PubMed ID: 35807039
[TBL] [Abstract][Full Text] [Related]
59. Improvement in quality-of-life measures and stimulation of weight gain after treatment with megestrol acetate oral suspension in geriatric cachexia: results of a double-blind, placebo-controlled study.
Yeh SS; Wu SY; Lee TP; Olson JS; Stevens MR; Dixon T; Porcelli RJ; Schuster MW
J Am Geriatr Soc; 2000 May; 48(5):485-92. PubMed ID: 10811540
[TBL] [Abstract][Full Text] [Related]
60. Megestrol acetate for anorexia and cachexia.
Loprinzi CL; Johnson PA; Jensen M
Oncology; 1992; 49 Suppl 2():46-9. PubMed ID: 1461628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
